Go Back
Northpond Ventures
Northpond Ventures, a venture fund established in 2018 and based in Bethesda, Maryland, focuses on Pre-Seed, Seed, and Series A stages. With a diverse portfolio spanning BioTech, Healthcare, AgTech, AI/ML, and more, they have invested in 93 companies and have seen 10 successful exits. Partnered with Sharon Kedar, Northpond Ventures supports innovative startups like Vizgen, Transition Bio, and Sherlock Biosciences. Their science-driven approach sets them apart in the industry, emphasizing biotechnology and related fields. For more information, visit their website at www.northpondventures.com.
About
About
About
Bio
Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.
Location
Bethesda, Maryland
Stage
Pre-Seed, Seed, Series A
Partner name
Sharon Kedar
Bio
Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.
Location
Bethesda, Maryland
Stage
Pre-Seed, Seed, Series A
Partner name
Sharon Kedar
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Medical Device, AgTech (FarmTech), Life Science, Information Technology, Artificial Intelligence & Machine Learning (AI/ML), Apps, CloudTech, Software, Pharmaceuticals, Advanced Materials, Big Data & Analytics
Number of investments
93
Number of exits
10
Fund Type
Venture Fund
Portfolio Companies
Vizgen, Vestaron, Transition Bio, Code Biotherapeutics, Scipher Medicine, Sound Agriculture, Triumvira Immunologics, Sherlock Biosciences, Story Health, StrideBio, Elephas, Scitara, Aro Biotherapeutics, Eleanor Health, Current Health, 64x Bio, Encodia, Totus Medicines, Ultivue, Personal Genome Diagnostics, 1859
Northpond Ventures
Northpond Ventures, a venture fund established in 2018 and based in Bethesda, Maryland, focuses on Pre-Seed, Seed, and Series A stages. With a diverse portfolio spanning BioTech, Healthcare, AgTech, AI/ML, and more, they have invested in 93 companies and have seen 10 successful exits. Partnered with Sharon Kedar, Northpond Ventures supports innovative startups like Vizgen, Transition Bio, and Sherlock Biosciences. Their science-driven approach sets them apart in the industry, emphasizing biotechnology and related fields. For more information, visit their website at www.northpondventures.com.
About
Bio
Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.
Location
Bethesda, Maryland
Stage
Pre-Seed, Seed, Series A
Partner name
Sharon Kedar
Fund
Fund Focus
BioTech, Healthcare, Medical Device, AgTech (FarmTech), Life Science, Information Technology, Artificial Intelligence & Machine Learning (AI/ML), Apps, CloudTech, Software, Pharmaceuticals, Advanced Materials, Big Data & Analytics
Number of investments
93
Number of exits
10
Fund Type
Venture Fund
Portfolio Companies
Vizgen, Vestaron, Transition Bio, Code Biotherapeutics, Scipher Medicine, Sound Agriculture, Triumvira Immunologics, Sherlock Biosciences, Story Health, StrideBio, Elephas, Scitara, Aro Biotherapeutics, Eleanor Health, Current Health, 64x Bio, Encodia, Totus Medicines, Ultivue, Personal Genome Diagnostics, 1859